Dublin AI startup Dasi Simulations raises $5M

DUBLIN, OHIO

Fueled by surging demand and widespread adoption, DASI Simulations’ AI-powered structural heart care predictive modeling technologies are driving unprecedented advancements in funding, commercialization, product development, and workforce expansion for the company.

“The first quarter saw significant commercialization progress, with 11 agreements finalized with centers in Arizona, California, Georgia, Massachusetts, South Carolina, Pennsylvania and New Jersey,” says Founder and CEO Teri Sirset. “Those include a key agreement with one of the largest structural heart centers in the U.S. We also have a robust pipeline of potential new contracts with 20 in the final contracting state and an additional 50-plus in earlier stages of negotiation.”

Product development continues. “One of our patent applications related to AI-based prediction of Thrombosis post-structural heart interventions was just granted allowance,” says Lakshmi (Prasad) Dasi, Founder and CTO. “We’ve also released a beta version of our post-TAVR gradient prediction tool, now supported by an article accepted for publication in the peer-reviewed Journal of Thoracic and Cardiovascular Surgery. “We’ve further automated the case processing pipeline, accelerating turnaround times and implemented an industry standard ticketing system for 24/7 customer service,” he adds.

Positive feedback from partner hospitals about our solutions and our reimbursement code continues to come in,” says Sirset. “In fact, a large center that has performed hundreds of cases reported a successful reimbursement rate of over 98% using our HCPCS code.”
 

To learn more, click here for the full article.